Location: Vienna, Austria
Date: September 15 to September 19
50th EASD Annual Meeting.
Medical Devices in Diabetes
Will SGLT2-inhibitors change the landscape?
Innate immunity in pancreatic islet inflammation
The artificial beta cell. When will the dream become reality?
Observational study of insulin pump treatment
The evidence for metformin is unclear?
The ORIGIN Study And Legacy Effects
Recent studies and future research directions
EASD on insulin pump safety concerns
Elements of personalized treatment in diabetes
Novelties in neuropathy?
EASD: Rapidly changing landscape of T2DM treatment
Fix combinations in type 2 diabetes mellitus
EASD: Role of EASD and PGEC in knowledge transfer
Second line treatment of type 2 diabetes mellitus
From incretin based therapies to SGLT2 inhibitors - individualized treatment of T2DM
EASD: Therapeutic and diagnostic novelties of 2014